-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2023 to Q3 2025.
- Inhibrx Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 15.5M shares, a 0.07% increase year-over-year.
- Inhibrx Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 15M shares, a 27.2% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)